(MORN) Morningstar - Overview
Stock: Data, Analytics, Platforms, Research, Ratings
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.76% |
| Yield on Cost 5y | 1.45% |
| Yield CAGR 5y | 17.80% |
| Payout Consistency | 96.1% |
| Payout Ratio | 26.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 55.9% |
| Relative Tail Risk | -3.46% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -2.37 |
| Alpha | -62.90 |
| Character TTM | |
|---|---|
| Beta | 0.869 |
| Beta Downside | 0.942 |
| Drawdowns 3y | |
|---|---|
| Max DD | 53.47% |
| CAGR/Max DD | -0.20 |
Description: MORN Morningstar January 02, 2026
Morningstar, Inc. (NASDAQ:MORN) delivers independent investment research and data services across North America, Europe, Asia-Pacific and other global markets through five operating segments: Data & Analytics, PitchBook, Wealth, Credit, and Retirement. Its product suite spans subscription-based platforms such as Morningstar Direct and Advisor Workstation, managed-investment vehicles (mutual funds, ETFs, model portfolios), private-capital intelligence via PitchBook, ESG ratings through Sustainalytics, and structured-finance analytics via DBRS.
Key recent metrics show the company generated approximately $1.1 billion in revenue for FY 2023, with subscription revenue representing roughly 70 % of total sales and posting a year-over-year growth rate of 9 %. The PitchBook segment has been expanding at an estimated 15 % CAGR, reflecting broader private-market fundraising activity, while ESG data demand has risen in line with a 12 % increase in global sustainable-investment assets under management. Macro-level drivers include rising interest-rate volatility (boosting credit-analytics usage) and continued regulatory emphasis on transparency in private-equity disclosures.
For a deeper quantitative view, you may want to explore ValueRay’s analyst platform.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 376.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA -1.37 > 1.0 |
| NWC/Revenue: 1.41% < 20% (prev 5.71%; Δ -4.30% < -1%) |
| CFO/TA 0.15 > 3% & CFO 539.1m > Net Income 376.0m |
| Net Debt (568.4m) to EBITDA (729.4m): 0.78 < 3 |
| Current Ratio: 1.04 > 1.5 & < 3 |
| Outstanding Shares: last quarter (42.6m) vs 12m ago -1.39% < -2% |
| Gross Margin: 60.93% > 18% (prev 0.61%; Δ 6032 % > 0.5%) |
| Asset Turnover: 67.25% > 50% (prev 62.33%; Δ 4.92% > 0%) |
| Interest Coverage Ratio: 13.69 > 6 (EBITDA TTM 729.4m / Interest Expense TTM 39.3m) |
Altman Z'' 4.06
| A: 0.01 (Total Current Assets 979.2m - Total Current Liabilities 945.5m) / Total Assets 3.56b |
| B: 0.59 (Retained Earnings 2.11b / Total Assets 3.56b) |
| C: 0.15 (EBIT TTM 538.2m / Avg Total Assets 3.56b) |
| D: 1.00 (Book Value of Equity 2.04b / Total Liabilities 2.04b) |
| Altman-Z'' Score: 4.06 = AA |
Beneish M -2.99
| DSRI: 1.03 (Receivables 363.9m/328.4m, Revenue 2.40b/2.22b) |
| GMI: 1.00 (GM 60.93% / 60.91%) |
| AQI: 1.01 (AQ_t 0.62 / AQ_t-1 0.61) |
| SGI: 1.08 (Revenue 2.40b / 2.22b) |
| TATA: -0.05 (NI 376.0m - CFO 539.1m) / TA 3.56b) |
| Beneish M-Score: -2.99 (Cap -4..+1) = A |
What is the price of MORN shares?
Over the past week, the price has changed by -18.12%, over one month by -23.26%, over three months by -21.64% and over the past year by -49.03%.
Is MORN a buy, sell or hold?
- StrongBuy: 1
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MORN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 280.7 | 69.6% |
| Analysts Target Price | 280.7 | 69.6% |
| ValueRay Target Price | 152 | -8.2% |
MORN Fundamental Data Overview February 04, 2026
P/E Forward = 17.9211
P/S = 3.4915
P/B = 5.49
Revenue TTM = 2.40b USD
EBIT TTM = 538.2m USD
EBITDA TTM = 729.4m USD
Long Term Debt = 848.9m USD (from longTermDebt, last quarter)
Short Term Debt = 39.9m USD (from shortTermDebt, last quarter)
Debt = 1.04b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 568.4m USD (from netDebt column, last quarter)
Enterprise Value = 8.89b USD (8.36b + Debt 1.04b - CCE 514.5m)
Interest Coverage Ratio = 13.69 (Ebit TTM 538.2m / Interest Expense TTM 39.3m)
EV/FCF = 22.56x (Enterprise Value 8.89b / FCF TTM 394.1m)
FCF Yield = 4.43% (FCF TTM 394.1m / Enterprise Value 8.89b)
FCF Margin = 16.45% (FCF TTM 394.1m / Revenue TTM 2.40b)
Net Margin = 15.70% (Net Income TTM 376.0m / Revenue TTM 2.40b)
Gross Margin = 60.93% ((Revenue TTM 2.40b - Cost of Revenue TTM 935.9m) / Revenue TTM)
Gross Margin QoQ = 60.85% (prev 61.89%)
Tobins Q-Ratio = 2.50 (Enterprise Value 8.89b / Total Assets 3.56b)
Interest Expense / Debt = 0.90% (Interest Expense 9.40m / Debt 1.04b)
Taxrate = 25.53% (31.4m / 123.0m)
NOPAT = 400.8m (EBIT 538.2m * (1 - 25.53%))
Current Ratio = 1.04 (Total Current Assets 979.2m / Total Current Liabilities 945.5m)
Debt / Equity = 0.69 (Debt 1.04b / totalStockholderEquity, last quarter 1.51b)
Debt / EBITDA = 0.78 (Net Debt 568.4m / EBITDA 729.4m)
Debt / FCF = 1.44 (Net Debt 568.4m / FCF TTM 394.1m)
Total Stockholder Equity = 1.59b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.56% (Net Income 376.0m / Total Assets 3.56b)
RoE = 23.66% (Net Income TTM 376.0m / Total Stockholder Equity 1.59b)
RoCE = 22.08% (EBIT 538.2m / Capital Employed (Equity 1.59b + L.T.Debt 848.9m))
RoIC = 16.79% (NOPAT 400.8m / Invested Capital 2.39b)
WACC = 8.18% (E(8.36b)/V(9.41b) * Re(9.12%) + D(1.04b)/V(9.41b) * Rd(0.90%) * (1-Tc(0.26)))
Discount Rate = 9.12% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.47%
[DCF Debug] Terminal Value 78.50% ; FCFF base≈414.0m ; Y1≈445.8m ; Y5≈547.2m
Fair Price DCF = 208.9 (EV 9.16b - Net Debt 568.4m = Equity 8.59b / Shares 41.1m; r=8.18% [WACC]; 5y FCF grow 8.65% → 2.90% )
EPS Correlation: 31.33 | EPS CAGR: -25.21% | SUE: -4.0 | # QB: 0
Revenue Correlation: 98.34 | Revenue CAGR: 8.03% | SUE: 0.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.51 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=10.83 | Chg30d=+0.032 | Revisions Net=+1 | Growth EPS=+14.8% | Growth Revenue=+7.5%